Global Oncology Biosimilars Market Insights and Forecast to 2026

SKU ID : QYR- 15910994

Publishing Date : 13-Jul-2020

No. of pages : 111

PRICE
3900
5850
7800

  • Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry. In the past few years, various biosimilars have been approved by FDA for the treatment of various types of cancer such as blood cancer, colorectal cancer, breast cancer, and others. In the near future, it is expected that a few more biosimilars will be introduced in the market thus supporting the growth of the market.

    Market Analysis and Insights: Global Oncology Biosimilars Market
    The global Oncology Biosimilars market size is projected to reach US$ 625.7 million by 2026, from US$ 474.2 million in 2020, at a CAGR of 29.6%% during 2021-2026.

    Global Oncology Biosimilars Scope and Market Size
    Oncology Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Oncology Biosimilars market is segmented into
    mAb
    Immunomodulators
    Hematopoietic Agents
    G-CSF
    Others

    Segment by Application, the Oncology Biosimilars market is segmented into
    Retail Pharmacies
    Hospital Pharmacy
    Online Pharmacy

    Regional and Country-level Analysis
    The Oncology Biosimilars market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Oncology Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape

    and Oncology Biosimilars Market Share Analysis
    Oncology Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology Biosimilars business, the date to enter into the Oncology Biosimilars market, Oncology Biosimilars product introduction, recent developments, etc.

    The major vendors covered:
    Celltrion
    Biocon
    Dr. Reddy’s Laboratories
    STADA Arzneimittel AG
    Intas Pharmaceuticals
    Pfizer
    Sandoz International
    Teva Pharmaceutical Industries Ltd
    Apotex
    BIOCAD

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports